?. Mohd-hanafiah, K. Groeger, J. Flaxman, A. Wiersma, and S. , Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence, Hepatology, vol.29, issue.Suppl, pp.1333-1375, 2013.
DOI : 10.1111/j.1478-3231.2008.01927.x

?. Scheel, T. Rice, and C. , Understanding the hepatitis C virus life cycle paves the way for highly effective therapies, Nature Medicine, vol.56, issue.7, pp.837-886, 2013.
DOI : 10.1073/pnas.0915117107

?. Hagan, L. Wolpe, P. Schinazi, and R. , Treatment as prevention and cure towards global eradication of hepatitis C virus, Trends in Microbiology, vol.21, issue.12, pp.625-658, 2013.
DOI : 10.1016/j.tim.2013.09.008

?. Suryaprasad, A. White, J. Xu, F. Eichler, B. Hamilton et al., Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, Clin Infect Dis, vol.59, pp.2006-20121411, 2014.

?. Ward and J. , The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease, Top Antivir Med, vol.21, pp.15-24, 2013.

?. Van-de-laar, T. Pybus, O. Bruisten, S. Brown, D. Nelson et al., Evidence of a Large, International Network of HCV Transmission in HIV-Positive Men Who Have Sex With Men, Gastroenterology, vol.136, issue.5, pp.1609-1626, 2009.
DOI : 10.1053/j.gastro.2009.02.006

?. Beaumont, E. Patient, R. Hourioux, C. Dimier-poisson, I. Roingeard et al., Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine, Hepatology, vol.8, issue.Suppl 1, pp.1303-1316, 2013.
DOI : 10.1016/S1473-3099(08)70126-9

URL : https://hal.archives-ouvertes.fr/inserm-00812948

?. Beaumont, E. Roingeard, and P. , Prospects for prophylactic hepatitis C vaccines based on virus-like particles, Human Vaccines & Immunotherapeutics, vol.12, issue.5, pp.1112-1120, 2013.
DOI : 10.1126/scitranslmed.3003155

URL : https://hal.archives-ouvertes.fr/inserm-00812949

?. Lua, L. Connors, N. Sainsbury, F. Chuan, Y. Wibowo et al., Bioengineering virus-like particles as vaccines, Biotechnology and Bioengineering, vol.376, issue.9744, pp.425-465, 2014.
DOI : 10.1016/S0140-6736(10)61030-6

?. Trépo, C. Chan, H. Lok, and A. , Hepatitis B virus infection, The Lancet, vol.384, issue.9959, pp.60220-60228, 2014.
DOI : 10.1016/S0140-6736(14)60220-8

?. Netter, H. Woo, W. Tindle, R. Macfarlan, R. Gowans et al., Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine, Vaccine, vol.21, issue.21-22, pp.2692-2699, 2003.
DOI : 10.1016/S0264-410X(03)00182-8

?. Chuan, Y. Rivera-hernandez, T. Wibowo, N. Connors, N. Wu et al., Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine, Biotechnology and Bioengineering, vol.11, issue.12, pp.2343-51, 2013.
DOI : 10.1016/0264-410X(93)90042-V

?. Lell, B. Agnandji, S. Von-glasenapp, I. Haertle, S. Oyakhiromen et al., A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon, PLoS ONE, vol.4, issue.10, p.7611, 2009.
DOI : 10.1371/journal.pone.0007611.s002

?. Who, Hepatitis B vaccines: WHO position paperrecommendations, Vaccine, vol.28, pp.589-90, 2010.

?. Chan, P. Ngai, K. Lao, T. Wong, M. Cheung et al., Response to Booster Doses of Hepatitis B Vaccine among Young Adults Who Had Received Neonatal Vaccination, PLoS ONE, vol.27, issue.9, p.107163, 2014.
DOI : 10.1371/journal.pone.0107163.g002